Product Composition & Structure

Search a product, then expand its tree to see how it is built — components, single parts, materials and packaging, each with its share. You always see where you are inside the product, and a click takes you to the companies (actors) that make it.

Pharmaceutical Products incl. Contraceptives and Vaccines › Antineoplastic agents › Hormones and antihormones › Bortezomib

Bortezomib

Product ID: 179061
1 materials 1 total parts
View companies that make this product
Filter:
Formulation 1 option — component shares are % of the finished formulation
Lyophilized Powder for Injection primary base: Bortezomib Proteasome inhibitor formulation
ComponentRoleShareSourceable matches
Mannitol Bulking agent
50% (40–60)
Mannitol 88% Mannitol myleran 67% Mannitol hexanitrate 62% Used In
Water for injection Solvent (removed during lyophilization)
47٫45% (36٫55–58٫35)
Sterile water for injection 78% Sterile water for inhalation 67% Sterile water for irrigation 63% Used In
Bortezomib Active ingredient
1٫5% (1–2)
Bortezomib 94% Carfilzomib 69% Pomalidomide 60% Used In
Sodium chloride Tonicity adjuster
0٫75% (0٫5–1)
Sodium chloride electrolytes 73% Potassium chloride/sodium chloride 66% Sodium chloride/sodium phosphate 65% Used In
Sodium hydroxide pH adjuster
0٫2% (0٫1–0٫3)
Sodium hydroxide 93% Potassium hydroxide 72% Calcium hydroxide 62% Used In
Hydrochloric acid pH adjuster
0٫1% (0٫05–0٫15)
Hydrochloric acid 86% Cleaning and disinfecting solutions 62% Clinical chemistry titrant reagents 61% Used In

Interactive Visual Tree Workbench

Explore visual hierarchical nodes, scale batch production quantities, and discover component suppliers.

kg
Component
Material BASE
Percentage (%): 0%
Required Weight: 0 kg
Find Suppliers for this Part